Evaxion Shares Positive Phase 2 Results for Personalized Cancer Vaccine EVX-01

Initial EVX-01 Phase 2 data confirms the strong Phase 1 results After undergoing EVX-01 treatment, a significant and continuous tumor reduction was ...

November 01, 2023 | Wednesday | News
Renaissance BioScience Achieves Groundbreaking RNA Tech Patent

Renaissance BioScience Corp., a leader in bioengineering for the global agriculture, animal health, human medicine, and food industries, is pleased to anno...

October 30, 2023 | Monday | News
LumaCyte Unveils Compact Radiance® Instrument for Biomanufacturing & QC in Advanced Therapy

LumaCyte, a leading innovator in advanced single cell analysis technology and instrumentation, is proud to announce the launch of their newly redesigned fl...

October 25, 2023 | Wednesday | News
Next-Gen Cologuard Test Outperforms FIT in Cancer Detection: BLUE-C Study Results

American College of Gastroenterology (ACG) gives BLUE-C study late breaker status at 2023 annual meeting with presentation of the only head-to-head study r...

October 23, 2023 | Monday | News
Charles River Launches Real-Time Research Model Ordering, a Digital Innovation

“Traditionally, clients looking to purchase research models would review a static digital catalog, and follow-up with a phone call or email to our or...

October 20, 2023 | Friday | News
Thermo Fisher Partners with Boehringer Ingelheim on Companion Diagnostic for NSCLC Treatment

To support emerging precision therapies and improve patient outcomes by increasing access to reliable genomic testing needed to match patients with targete...

October 20, 2023 | Friday | News
Fluor Empowers Bayer's Cell Therapy Innovation with State-of-the-Art Facility in Berkeley, California

Fluor Corporation  announced that it has completed construction of Bayer’s first global Cell Therapy Launch Facility in Berkeley, California. Co...

October 19, 2023 | Thursday | News
Thermo Fisher Scientific to Acquire Olink, a Leader in Next-Generation Proteomics

Complements Existing Life Sciences and Mass Spectrometry Offerings, Accelerating Protein Biomarker Discovery and Providing Strong Synergy Opportuniti...

October 18, 2023 | Wednesday | News
Integrated DNA Technologies Opens New Facility for Growing Genomic Medicine Demand

Global genomics solutions provider Integrated DNA Technologies (IDT), an operating company in the Life Sciences segment of Danaher Corporation (NYSE:DHR), ...

October 18, 2023 | Wednesday | News
Proteintech launches New Multi-rAb Recombinant Secondary Antibodies

Proteintech, a global leader in antibodies, immunoassay kits, and recombinant proteins,announced the launch of Multi-rAb Recombinant Secondary Antibodies, ...

October 17, 2023 | Tuesday | News
Multiply Labs Teams Up with UC San Francisco, Cytiva, Thermo Fisher, and Charles River for Robotic Cell Therapy Proof-of-Concept

Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs (including but not limited to...

October 12, 2023 | Thursday | News
Aidoc and Mayo Clinic Platform Provide End-to-End AI Support to Maximize Patient Care

Aidoc, a pioneer in clinical AI technology, and Mayo Clinic Platform are working together to improve care by providing access to Aidoc's AI technology and ...

October 10, 2023 | Tuesday | News
Japan's Kaneka Sues CoCrysta for Patent Infringement

The protection of Kaneka's intellectual property stands as a paramount cornerstone of its business. Kaneka's commitment to safeguarding these rights is unw...

October 10, 2023 | Tuesday | News
Be The Match BioTherapies® & Cryoport Join Forces for Cell & Gene Therapy Advancement

 Be The Match BioTherapies®, an organization offering solutions for companies developing and commercializing cell and gene therapies, and Cryoport...

October 10, 2023 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close